Cargando…
Transvenous Phrenic Nerve Stimulation for Treatment of Central Sleep Apnea: Five-Year Safety and Efficacy Outcomes
BACKGROUND: The remedē System Pivotal Trial was a prospective, multi-center, randomized trial demonstrating transvenous phrenic nerve stimulation (TPNS) therapy is safe and effectively treats central sleep apnea (CSA) and improves sleep architecture and daytime sleepiness. Subsequently, the remedē S...
Autores principales: | Costanzo, Maria Rosa, Javaheri, Shahrokh, Ponikowski, Piotr, Oldenburg, Olaf, Augostini, Ralph, Goldberg, Lee R, Stellbrink, Christoph, Fox, Henrik, Schwartz, Alan R, Gupta, Sanjaya, McKane, Scott, Meyer, Timothy E, Abraham, William T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092633/ https://www.ncbi.nlm.nih.gov/pubmed/33953626 http://dx.doi.org/10.2147/NSS.S300713 |
Ejemplares similares
-
Long-term efficacy and safety of phrenic nerve stimulation for the treatment of central sleep apnea
por: Fox, Henrik, et al.
Publicado: (2019) -
Phrenic nerve stimulation to treat patients with central sleep apnoea and heart failure
por: Costanzo, Maria Rosa, et al.
Publicado: (2018) -
Improving Nocturnal Hypoxemic Burden with Transvenous Phrenic Nerve Stimulation for the Treatment of Central Sleep Apnea
por: Oldenburg, Olaf, et al.
Publicado: (2020) -
Transvenous phrenic nerve stimulation improves central sleep apnea, sleep quality, and quality of life regardless of prior positive airway pressure treatment
por: Schwartz, Alan R., et al.
Publicado: (2021) -
Transvenous phrenic nerve stimulation is associated with normalization of nocturnal heart rate perturbations in patients with central sleep apnea
por: Baumert, Mathias, et al.
Publicado: (2023)